Global Medical Information

Novavax Medical Information

DISCLAIMER: THIS PAGE IS INTENDED FOR HEALTHCARE PROFESSIONALS IN Germany ONLY.

If you are NOT a Healthcare Professional in Germany, please switch to the Consumer Medical Information page.

Adverse Event Reporting
Product Quality Complaint
Product Information
Medical Information

Information on the NuvaxovidTM XBB.1.5▼ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted)

If your enquiry is regarding the NuvaxovidTM XBB.1.5▼ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted), you can find some useful information in the resources below.

Nuvaxovid XBB.1.5 Summary of Product Characteristics (SmPC)
Learn More
Nuvaxovid XBB.1.5 Product Information Leaflet (PIL)
Learn More

Request Medical Information

Healthcare Professionals may request medical information via ONE of the following ways:

Option 1: Complete and submit a Medical Information Request Form by clicking on the button below.

Request Medical Information

Option 2: Call +49 800 1813940 between 09:00–17:00.

Report an Adverse Event (AE)

If you are concerned about an adverse event, it should be reported to the Paul-Ehrlich-Institut at www.pei.de.

Alternatively, adverse events of serious concern in association with a Novavax product can be reported to Novavax Pharmacovigilance at +49 800 1813940 or via the Novavax  Adverse Event Reporting Form.

Report a Product Quality Complaint

If you have a product quality complaint related to a physical issue with a Novavax product or its packaging, please call +49 800 1813940 between 09:00–17:00.